These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3412108)

  • 1. Antiarrhythmic action of naloxone: direct, non-opiate effect on the rat heart.
    Sarne Y; Hochman I; Eshed M; Oppenheimer E
    Life Sci; 1988; 43(10):859-64. PubMed ID: 3412108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiarrhythmic action of naloxone. Suppression of picrotoxin-induced cardiac arrhythmias in the rat.
    Lin CJ; Chen YT; Kuo JS; Lee AY
    Jpn Heart J; 1992 May; 33(3):365-72. PubMed ID: 1522693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereospecific antiarrhythmic effects of naloxone against myocardial ischaemia and reperfusion in the dog.
    Lee AY
    Br J Pharmacol; 1992 Dec; 107(4):1057-60. PubMed ID: 1467828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Negative chronotropic but no antiarrhythmic effect of (+)- and (-)-naloxone in rats and guinea pigs.
    Kaschube M; Brasch H
    Cardiovasc Res; 1991 Mar; 25(3):230-4. PubMed ID: 2029712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of naloxone on rhythm disorders and on the conduction system of the heart].
    Shliakhto EV; Zaĭtsev AA; Panov AV; Ardashev AV; Nifontov EM; Kashina EA; Kazarin VV; Ivanov VV
    Eksp Klin Farmakol; 1996; 59(3):34-6. PubMed ID: 8974581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ventricular arrhythmia incidence in the rat is reduced by naloxone.
    Pugsley MK; Hayes ES; Wang WQ; Walker MJ
    Pharmacol Res; 2015 Jul; 97():64-9. PubMed ID: 25920674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The participation of the mu-, delta- and kappa-opioid receptors in the realization of the anti-arrhythmia effect of Rhodiola rosea].
    Maĭmeskulova LA; Maslov LN; Lishmanov IuB; Krasnov EA
    Eksp Klin Farmakol; 1997; 60(1):38-9. PubMed ID: 9162281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-arrhythmic activities of opioid agonists and antagonists and their stereoisomers.
    Sarne Y; Flitstein A; Oppenheimer E
    Br J Pharmacol; 1991 Mar; 102(3):696-8. PubMed ID: 1364840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Verapamil has antiarrhythmic effects that are mediated in brain through endogenous opioids.
    Rabkin SW
    J Cardiovasc Pharmacol; 1994 May; 23(5):814-21. PubMed ID: 7521466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interaction between ethanol and amiodarone, in the model of adrenaline arrhythmia in the rat.
    Filipek B; Krupińska J; Librowski T; Piekoszewski W
    Pol J Pharmacol Pharm; 1989; 41(3):213-8. PubMed ID: 2616377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac antiarrhythmic evaluation of naloxone with or without propranolol using a modified chloroform-hypoxia screening test in the rat.
    Wong TM; Lee AY
    Clin Exp Pharmacol Physiol; 1985; 12(4):379-85. PubMed ID: 4092371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The anti-arrhythmia and pro-arrhythmia properties of sigma-receptor ligands].
    Lishmanov IuB; Maslov LN; Krylatov AV; Ugdyzhekova DS; Gilligan P; Tam SW
    Eksp Klin Farmakol; 2000; 63(2):39-43. PubMed ID: 10834092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [An experimental study of the pharmacological activity of opiate receptor ligands on models of adrenaline-induced arrhythmias].
    Lishmanov IuB; Maslov LN; Ugdyzhekova DS
    Eksp Klin Farmakol; 1995; 58(4):26-8. PubMed ID: 7580747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The participation of the central and peripheral kappa-opiate receptors in the mechanism of the anti-arrhythmia action of benzeneacetamide derivatives].
    Maslov LN; Lishmanov IuB; Krylatov AV; Ugdyzhekova DS
    Eksp Klin Farmakol; 1996; 59(6):20-2. PubMed ID: 9181865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-arrhythmic effect of phytoadaptogens].
    Maĭmeskulova LA; Maslov LN
    Eksp Klin Farmakol; 2000; 63(4):29-31. PubMed ID: 11022302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The mechanism of the anti-arrhythmia action of opioid receptor agonists and antagonists].
    Maslov LN; Lishmanov IuB; Székely JI
    Biull Eksp Biol Med; 1993 Aug; 116(8):169-71. PubMed ID: 7506071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The anti-arrhythmic activity of agonists of the peripheral mu-opiate receptors].
    Maslov LN; Krylatov AV; Lishmanov IuB
    Eksp Klin Farmakol; 1999; 62(3):28-31. PubMed ID: 10439944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naloxone reversal of ischemic arrhythmia is stereospecific and suggests role of endogenous opioid peptides in ischemic heart disease.
    Kan MN; Chen YT; Lee AY
    Proc Soc Exp Biol Med; 1992 Sep; 200(4):518-21. PubMed ID: 1508943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cardioprotective and antiarrhythmic properties of Rhodiolae roseae preparations].
    Maslov LN; Lishmanov IuB
    Eksp Klin Farmakol; 2007; 70(5):59-67. PubMed ID: 18074810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The development of ischemic cardiac arrhythmias during naloxone blockade of the opiate receptors].
    Kositskiĭ GI; Mikhaĭlova SD; Gorozhanin SL; Semushkina TM
    Biull Eksp Biol Med; 1989 May; 107(5):528-30. PubMed ID: 2544233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.